Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
QSAM Biosciences (QSAM)
OTHER OTC:QSAM
QSAM Biosciences (QSAM) Stock Price & Analysis
5 Followers
QSAM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.50 - $10.50
Previous Close$3.93
Volume200.00
Average Volume (3M)1.56K
Market Cap
$7.54M
Enterprise Value$7.93M
Total Cash (Recent Filing)$899.29K
Total Debt (Recent Filing)$567.13K
Price to Earnings (P/E)-0.8
Beta-0.43
Next Earnings
May 16, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.22
Shares Outstanding1,922,142
10 Day Avg. Volume1,099
30 Day Avg. Volume1,563
Standard Deviation0.38
R-Squared0.11
Alpha-0.00439
Financial Highlights & Ratios
Price to Book (P/B)-3.13
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
QSAM Biosciences News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QSAM FAQ
What was QSAM Biosciences’s price range in the past 12 months?
QSAM Biosciences lowest stock price was $3.50 and its highest was $10.50 in the past 12 months.
What is QSAM Biosciences’s market cap?
Currently, no data Available
When is QSAM Biosciences’s upcoming earnings report date?
QSAM Biosciences’s upcoming earnings report date is May 16, 2023 which is in 49 days.
How were QSAM Biosciences’s earnings last quarter?
QSAM Biosciences released its earnings results on Nov 15, 2022. The company reported -$0.753 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.753.
Is QSAM Biosciences overvalued?
According to Wall Street analysts QSAM Biosciences’s price is currently Overvalued.
Does QSAM Biosciences pay dividends?
QSAM Biosciences does not currently pay dividends.
What is QSAM Biosciences’s EPS estimate?
QSAM Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QSAM Biosciences have?
QSAM Biosciences has 1,922,142 shares outstanding.
What happened to QSAM Biosciences’s price movement after its last earnings report?
QSAM Biosciences reported an EPS of -$0.753 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.13%.
Which hedge fund is a major shareholder of QSAM Biosciences?
Currently, no hedge funds are holding shares in QSAM
---
QSAM Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.86%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
QSAM Biosciences
Q2Earth, Inc. is a holding company, which engages in the process and provision of renewable energy. Its product portfolio includes waste water treatment plants, landfills, and livestock farms. The company was founded by Christopher M. Nelson on August 26, 2004 and is headquartered in Palm Beach, FL.
---
Cyclacel Pharmaceuticals
―
Eterna Therapeutics
―
Bellerophon
―
Kintara Therapeutics
―
BioRestorative Therapies
―
---